Diagnostic Value of Multiparameter MRI-Based Radiomics in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disorders

References

1. 1.↵
   1. Wynford-Thomas R,
   2. Jacob A,
   3. Tomassini V

   . Neurological update: MOG antibody disease. J Neurol 2019;266:1280–86 doi:10.1007/s00415-018-9122-2 pmid:30569382

   CrossRefPubMed
2. 2.↵
   1. Jarius S,
   2. Ruprecht K,
   3. Kleiter I, et al

   ; in cooperation with the Neuromyelitis Optica Study Group (NEMOS). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 2016;13:280 doi:10.1186/s12974-016-0718-0 pmid:27793206

   CrossRefPubMed
3. 3.↵
   1. Bruijstens AL,
   2. Lechner C,
   3. Flet-Berliac L, et al

   ; E.U. Paediatric MOG Consortium. E.U. Paediatric MOG Consortium consensus, Part 1: classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 2020;29:2–13 doi:10.1016/j.ejpn.2020.10.006 pmid:33162302

   CrossRefPubMed
4. 4.↵
   1. Armangue T,
   2. Olive-Cirera G,
   3. Martinez-Hernandez E, et al

   ; Spanish Pediatric anti-MOG Study Group. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol 2020;19:234–46 doi:10.1016/S1474-4422(19)30488-0 pmid:32057303

   CrossRefPubMed
5. 5.↵
   1. Narayan R,
   2. Simpson A,
   3. Fritsche K, et al

   . MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 2018;25:66–72 doi:10.1016/j.msard.2018.07.025 pmid:30048919

   CrossRefPubMed
6. 6.↵
   1. Hennes EM,
   2. Baumann M,
   3. Lechner C, et al

   . MOG spectrum disorders and role of MOG-antibodies in clinical practice. Neuropediatrics 2018;49:3–11 doi:10.1055/s-0037-1604404 pmid:28859212

   CrossRefPubMed
7. 7.↵
   1. Baumann M,
   2. Grams A,
   3. Djurdjevic T, et al

   . MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein. J Neurol 2018;265:845–55 doi:10.1007/s00415-018-8781-3 pmid:29423614

   CrossRefPubMed
8. 8.↵
   1. Mayerhoefer ME,
   2. Materka A,
   3. Langs G, et al

   . Introduction to radiomics. J Nucl Med 2020;61:488–95 doi:10.2967/jnumed.118.222893 pmid:32060219

   Abstract/FREE Full Text
9. 9.↵
   1. Eichinger P,
   2. Zimmer C,
   3. Wiestler B

   . AI in radiology: where are we today in multiple sclerosis imaging? Rofo 2020;192:847–53 doi:10.1055/a-1167-8402 pmid:32643769

   CrossRefPubMed
10. 10.↵
    1. Fernandez-Carbonell C,
    2. Vargas-Lowy D,
    3. Musallam A, et al

    . Clinical and MRI phenotype of children with MOG antibodies. Mult Scler 2016;22:174–84 doi:10.1177/1352458515587751 pmid:26041801

    CrossRefPubMed
11. 11.↵
    1. Mao L,
    2. Yang L,
    3. Kessi M, et al

    . Myelin oligodendrocyte glycoprotein (MOG) antibody diseases in children in central south China: clinical features, treatments, influencing factors, and outcomes. Front Neurol 2019;10:868 doi:10.3389/fneur.2019.00868 pmid:31440204

    CrossRefPubMed
12. 12.↵
    1. Borisow N,
    2. Mori M,
    3. Kuwabara S, et al

    . Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis. Front Neurol 2018;9:888 doi:10.3389/fneur.2018.00888 pmid:30405519

    CrossRefPubMed
13. 13.↵
    1. Cross H,
    2. Sabiq F,
    3. Ackermans N, et al

    . Myelin oligodendrocyte glycoprotein (MOG) antibody positive patients in a multi-ethnic Canadian cohort. Front Neurol 2020;11:525933 doi:10.3389/fneur.2020.525933 pmid:33510701

    CrossRefPubMed
14. 14.↵
    1. Fornacon-Wood I,
    2. Faivre-Finn C,
    3. O’Connor JP, et al

    . Radiomics as a personalized medicine tool in lung cancer: separating the hope from the hype. Lung Cancer 2020;146:197–208 doi:10.1016/j.lungcan.2020.05.028 pmid:32563015

    CrossRefPubMed
15. 15.↵
    1. He T,
    2. Zhao W,
    3. Mao Y, et al

    . MS or not MS: T2-weighted imaging (T2WI)-based radiomic findings distinguish MS from its mimics. Mult Scler Relat Disord 2022;61:103756 doi:10.1016/j.msard.2022.103756 pmid:35397290

    CrossRefPubMed
16. 16.↵
    1. Huang J,
    2. Xin B,
    3. Wang X, et al

    . Multi-parametric MRI phenotype with trustworthy machine learning for differentiating CNS demyelinating diseases. J Transl Med 2021;19:377 doi:10.1186/s12967-021-03015-w pmid:34488799

    CrossRefPubMed
17. 17.↵
    1. Peng Y,
    2. Zheng Y,
    3. Tan Z, et al

    . Prediction of unenhanced lesion evolution in multiple sclerosis using radiomics-based models: a machine learning approach. Mult Scler Relat Disord 2021;53:102989 doi:10.1016/j.msard.2021.102989 pmid:34052741

    CrossRefPubMed
18. 18.↵
    1. Kang D,
    2. Park JE,
    3. Kim YH, et al

    . Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation. Neuro Oncol 2018;20:1251–61 doi:10.1093/neuonc/noy021 pmid:29438500

    CrossRefPubMed
19. 19.↵
    1. Bathla G,
    2. Priya S,
    3. Liu Y, et al

    . Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques. Eur Radiol 2021;31:8703–13 doi:10.1007/s00330-021-07845-6 pmid:33890149

    CrossRefPubMed
20. 20.↵
    1. Huh SY,
    2. Min JH,
    3. Kim W, et al

    . The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler 2014;20:695–704 doi:10.1177/1352458513506953 pmid:24072726

    CrossRefPubMed
21. 21.↵
    1. Ma X,
    2. Zhang L,
    3. Huang D, et al

    . Quantitative radiomic biomarkers for discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis. J Magn Reson Imaging 2019;49:1113–21 doi:10.1002/jmri.26287 pmid:30408268

    CrossRefPubMed
22. 22.↵
    1. Lavrova E,
    2. Lommers E,
    3. Woodruff HC, et al

    . Exploratory radiomic analysis of conventional vs. quantitative brain MRI: toward automatic diagnosis of early multiple sclerosis. Front Neurosci 2021;15:679941 doi:10.3389/fnins.2021.679941 pmid:34421515

    CrossRefPubMed